Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response. - Wikidata - awgldk - TriplyDB

Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response.

Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response.

http://www.wikidata.org/entity/Q37124717

about

Obesity and recurrence‐free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C.

P2860

Q55533192-F7CE2B91-0E01-4E0C-B41C-0E9C76DCCC33

P2860

Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response.

http://www.wikidata.org/entity/Q37124717

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@en

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@nl

type

label

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@en

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@nl

prefLabel

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@en

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@nl

P1433

Q37124717-F6C233ED-3445-4801-97FC-02336B3B5B9C

P1476

Q37124717-0F75AE8A-0EF6-4CF2-9907-3A8F377D53F2

P2093

Q37124717-97AB92E9-0EDA-4CD3-A9BB-563945D5676B

P2860

Q37124717-13FE4EB0-75FA-4203-8375-82937E484D49

Q37124717-16060421-8CC3-4845-AC6B-2BB23C164452

Q37124717-2DEB1F4B-94A0-4332-BED2-FF4F6A409910

Q37124717-41A0DA5B-65D8-47E9-8CA3-F8591B36F381

Q37124717-57DD2F2B-8401-48D4-B181-6609CC91BCE6

Q37124717-5EF2F459-BC4E-466D-BEE3-BA57BBA7D831

Q37124717-63BBC849-D350-4603-A5DE-74130979A60B

Q37124717-67B1AECF-8FD0-46A1-A7F4-3B83EAA427F7

Q37124717-67C7A2A0-075D-496A-8014-857077CB3D98

Q37124717-6A1BD2A2-5B46-4C84-A13E-07EDC4627EE9

P304

Q37124717-74505F41-A3F8-4FF6-BFE9-5E76FFC16434

P31

Q37124717-EBB6128C-2F0E-4824-BA7C-6F20490225BE

Q37124717-fb948d61-723a-443d-95a3-bdad02433ff1

P356

Q37124717-CF637310-E6CA-4577-A8E4-3F72B09D93AB

P433

Q37124717-DC4F1A5B-0D47-4711-89AD-DB08C8F1E628

P478

Q37124717-502295C0-136B-4003-85BF-52DD92C24556

P577

Q37124717-CD79581B-AF98-489C-938A-8E4269A6D286

P698

Q37124717-0E1E742B-9ADE-40D9-8DE9-50B8F15B9E7A

P921

Q37124717-BBE0BB35-CFD4-4FB4-BA4E-8F4F29BE2B9C

P932

Q37124717-CE6DAB40-B900-4274-AC1F-04F7CF10E35E

P356

P1433

P1476

Risk of Hepatocellular Carcino ...... ustained Virological Response.

@en

P2093

M Kudo

http://www.w3.org/2001/XMLSchema#string

P2860

Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan

Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.

A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.

Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.

Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients.

The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.

Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan.

P304

155-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000443563

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27493891

http://www.w3.org/2001/XMLSchema#string

P921

P932

4960361

http://www.w3.org/2001/XMLSchema#string